keyboard_arrow_up

The Pre-Filled Syringes Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

The Pre-Filled Syringes Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts is a new market research publication announced by Reportstack. A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional ‘vial and syringe’ format, by increasing dosing accuracy, safety and convenience.

In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient).

The Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years.  Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020.

The “Pre-Filled Syringes Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2015 through to 2030. The forecasts are further segmented for 4 horizontal submarkets, 10 drug classes, 5 regions and 13 leading countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report."

"Key Findings:
The report has the following key findings:
 - The Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020
 - Many pre-filled syringe manufacturers now also offer integrated automatic needle shielding or retractable needle options
 - While glass continues to remain the gold standard for pre-filled syringes, the proportion of plastic based pre-filled syringes is expected to increase by 5% between 2015 and 2020, due to concerns of glass breakage and plunger failure
 - A number of pre-filled syringe manufacturers have developed dual and multi chambered syringes, to cater for drugs that must be reconstituted at the point of delivery
 - Pre-filled pen systems and auto-injectors will grow at a CAGR of more than 20% over the next five years

Topics Covered:
The report covers the following topics:
 - Pre-filled syringes ecosystem
 - Market drivers and barriers
 - Technology, safety mechanisms and key trends
 - Pen systems and auto-injectors
 - Industry roadmap and value chain
 - Analysis of leading drug classes and pre-filled syringe therapies
 - Profiles and strategies of 55 leading ecosystem players, including manufacturers and pharmaceutical giants
 - Strategic recommendations for ecosystem players
 - Market analysis and forecasts from 2015 till 2030

Historical Revenue & Forecast Segmentation:
Market forecasts are provided for each of the following submarkets and their subcategories:
Material
 - Glass
 - Plastic
Injector Type
 - Conventional
 - Pen Systems & Auto-Injectors
Drug Class
 - MAbs (Monoclonal Antibodies)
 - Insulins
 - Erythropoietins
 - Interferons
 - G-CSF Agents
 - Anticoagulants & Recombinant Coagulation Factors
 - Biosimilars & Follow-on Protein Products
 - Vaccines
 - Growth Hormones
 - Others
Regional Markets
 - Asia Pacific
 - Europe
 - Middle East & Africa
 - North America
 - Latin & Central America
Country Markets
 - Brazil
 - Canada
 - China
 - France
 - Germany
 - India
 - Italy
 - Japan
 - Korea
 - Russia
 - Spain
 - UK
 - USA

Some of the Companies Mentioned are:

"Abbott Laboratories
Amgen
AMRI (Albany Molecular Research, Inc.)
Aptar Stelmi
AptarGroup
Artemes Technologies
AstraZeneca
Battelle
Baxter International (Baxter BioPharma Solutions)
BD (Becton, Dickinson and Company)
Bespak
Biocon
Bioneer
Boehringer Ingelheim
BSM (Bristol-Myers Squibb)
Catalent Pharma Solutions
Chugai Pharmaceuticals
Coldstream Laboratories
Consort Medical
Covidien
Daiko Seiko
Dätwyler Holding
Elcam Medical
Eli Lilly and Company
FDA (U.S. Food and Drug Administration)
Fischer Clinical Services
Genentech
Gerresheimer
GSK (GlaxoSmithKline)
Haselmeier
Hospira
Hyaluron
Janssen Biotech
Janssen Research & Development
Johnson & Johnson
Laboratorios Farmacéuticos ROVI
Liebmann Group
LTI (Lyophilization Technology, Inc.)
Medilet
MedPro Safety Products
Medtronic
Merck and Co.
MGlas
Nipro Corporation
Novartis International
Novo Nordisk
Ompi (Stevanato Group)
Owen Mumford
PA Consulting
Pfanstiehl
Pfizer
Revolutions Medical Corporation
Ypsomed Holding
Yukon Medical
Zogenix"

To access full report with TOC, please visit The Pre-Filled Syringes Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts.